Source Natural Foods & Herbal Supplements Share Price

  • 180.004.85 (2.76%)
  • Volume: 1,424
BSE
  • Closed
  • Last Updated On: 13 Jun, 2025, 03:30 PM IST
Loading...
Source Natural Foods & Herbal Supplements Share Price
  • 180.004.85 (2.76%)
  • Volume: 1,424
Advertisment

Source Natural share price insights

View All
  • Company witnessed QoQ revenue growth of 54.25%, which is highest in the last 3 years. (Source: Standalone Financials)

  • Company's annual revenue growth of 64.82% outperformed its 3 year CAGR of 26.6%. (Source: Standalone Financials)

  • Company has spent 1.39% of its operating revenues towards interest expenses and 7.28% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Source Natural Foods & Herbal Supplements Ltd. share price moved up by 2.76% from its previous close of Rs 175.15. Source Natural Foods & Herbal Supplements Ltd. stock last traded price is 180.00

    Share PriceValue
    Today/Current/Last-180.00
    Previous Day-175.15

InsightsSource Natural

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    38.75
    EPS - TTM
    (₹)
    4.51
    MCap
    (₹ Cr.)
    112.74
    Sectoral MCap Rank
    132
    PB Ratio
    (x)
    5.79
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.22
    3 Months0.29
    6 Months0.16
    1 Year0.18
    3 Years0.18

    0.22
    VWAP
    (₹)
    169.72
    52W H/L
    (₹)
    269.75 / 91.87

    Source Natural Share Price Returns

    1 Day2.76%
    1 Week2.95%
    1 Month10.23%
    3 Months30.86%
    1 Year88.15%
    3 Years91.49%
    5 Years229.67%

    ET Stock ScreenersTop Score Companies

    Check whether Source Natural belongs to analysts' top-rated companies list?

    View Stock Screeners

    Source Natural Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Source Natural Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Source Natural Financials

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 54.25%, which is highest in the last 3 years. (Source: Standalone Financials)
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 64.82% outperformed its 3 year CAGR of 26.6%. (Source: Standalone Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income16.1210.4510.268.176.83
      Total Income Growth (%)54.251.9325.5319.62-14.60
      Total Expenses15.099.049.147.525.65
      Total Expenses Growth (%)66.89-1.0621.4833.08-13.09
      EBIT1.031.411.120.651.18
      EBIT Growth (%)-26.7326.4172.73-45.06-21.17
      Profit after Tax (PAT)0.631.020.840.420.32
      PAT Growth (%)-38.4321.26100.0030.29-66.56
      EBIT Margin (%)6.4113.5010.887.9117.22
      Net Profit Margin (%)3.899.748.195.144.72
      Basic EPS (₹)0.971.581.300.650.50
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue45.0027.3019.8022.0225.22
      Total Revenue Growth (%)64.8237.89-10.07-12.7085.23
      Total Expenses41.4224.0817.0618.3421.17
      Total Expenses Growth (%)72.0441.08-6.93-13.4079.92
      Profit after Tax (PAT)2.901.742.122.433.37
      PAT Growth (%)67.23-18.13-12.80-27.90105.76
      Operating Profit Margin (%)9.3612.5315.0117.8116.68
      Net Profit Margin (%)6.466.3610.7211.3013.56
      Basic EPS (₹)4.512.703.303.785.24

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets37.3323.6521.6919.3217.22
      Total Assets Growth (%)57.849.0412.2712.2031.05
      Total Liabilities14.984.203.973.734.06
      Total Liabilities Growth (%)256.675.796.43-8.1321.19
      Total Equity22.3619.4517.7215.6013.16
      Total Equity Growth (%)14.969.7613.5918.5434.42
      Current Ratio (x)1.924.984.913.763.01
      Total Debt to Equity (x)0.330.000.000.000.07
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities0.072.692.51-4.42
      Net Cash used in Investing Activities-5.330.290.06--2.05
      Net Cash flow from Financing Activities5.40-0.04-0.53-0.32
      Net Cash Flow0.132.952.04-2.69
      Closing Cash & Cash Equivalent7.235.862.91-2.71
      Closing Cash & Cash Equivalent Growth (%)23.27101.177.690.000.00
      Total Debt/ CFO (x)113.140.000.01-0.21

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)12.988.9211.9715.5925.63
      Return on Capital Employed (%)18.3417.0816.2623.7930.65
      Return on Assets (%)7.777.349.7712.5819.58
      Interest Coverage Ratio (x)8.3723.0614.4627.8440.00
      Asset Turnover Ratio (x)1.471.200.961.18144.45
      Price to Earnings (x)46.3032.7927.0325.1928.25
      Price to Book (x)5.992.923.233.927.24
      EV/EBITDA (x)25.6911.4015.9614.1920.69
      EBITDA Margin (%)11.6216.3517.2019.7418.16

      No reported Financial Ratios are available.

    Financial InsightsSource Natural

    • Income (P&L)
      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 54.25%, which is highest in the last 3 years. (Source: Standalone Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 64.82% outperformed its 3 year CAGR of 26.6%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Source Natural Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Source Natural Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Source Natural38.755.7912.9818.347.7726.609.366.464.511.920.33113.14
      Auro Labs114.964.164.273.821.85-26.9615.279.472.950.991.057.83
      Aarey Drugs37.171.132.907.151.68-0.782.130.841.842.200.253.61
      Welcure Drugs28.09-138.750.00-56.37-25.74520.10-246.64-432.16-1.460.49-2.972.81
      Bharat Immunological -6.081.28-19.42-16.78-9.18-11.23-35.44-38.23-3.950.360.806.45
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Samrat Pharma
      • Mercury Laboratories
      • Ind Swift Ltd
      • Makers Labs
      • Biofil Chem

      Choose from Stocks

      Peers InsightsSource Natural

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Source Natural Shareholding Pattern

        • Loading...
          Showing Source Natural Shareholding as on Mar 2025
          CategoryMar 2025Dec 2024Sep 2024Jun 2024
          Promoters74.3774.3774.3774.37
          Pledge0.000.000.000.00
          FII0.000.000.000.00
          DII0.000.000.000.00
          Mutual Funds0.000.000.000.00
          Others25.6225.6225.6225.62
        • Showing Shareholding as on Mar 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters47,86,89174.37 %0.00
          Pledge00.00 %0.00
          Others16,50,04025.62 %0.00

        Source Natural MF Ownership

        MF Ownership details are not available.

        Source Natural Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          May 29, 2025May 26, 2025Board MeetingAudited Results
          Feb 13, 2025Feb 06, 2025Board MeetingQuarterly Results
          Jan 28, 2025Dec 26, 2024POM-
          Nov 12, 2024Nov 07, 2024Board MeetingQuarterly Results
          Sep 30, 2024Sep 06, 2024AGMBook closure from Sep 24, 2024 to Sep 30, 2024
        • Dividend announcements are not available.

        • No other corporate actions details are available.

        About Source Natural

        Source Natural Foods & Herbal Supplements Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 115.86 Crore) operating in Pharmaceuticals sector. Source Natural Foods & Herbal Supplements Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2024. Show More

        • Executives

        • Auditors

        • NN

          Narayanan Narasimhan

          Chairman & Non-Exe.Director
          NA

          N Arvind Varchaswi

          Managing Director
          B

          Bharathy

          Independent Director
          CL

          Chandrakant Laxminarayan Rathi

          Independent Director
          Show More
        • Srinaga & Giridharan

        FAQs about Source Natural share

        • 1. What's Source Natural share price today and what are Source Natural share returns ?
          As on 13 Jun, 2025, 03:30 PM IST Source Natural share price is up by 2.76% basis the previous closing price of Rs 182.55. Source Natural share price is Rs 180.00. Return Performance of Source Natural Shares:
          • 1 Week: Source Natural share price moved up by 2.95%
          • 1 Month: Source Natural share price moved up by 10.23%
          • 3 Month: Source Natural share price moved up by 30.86%
          • 6 Month: Source Natural share price moved down by 19.28%
        • 2. What is Source Natural's 52 week high / low?
          Source Natural share price saw a 52 week high of Rs 269.75 and 52 week low of Rs 91.87.
        • 3. Who's the owner of Source Natural?
            • Promoter holding has not changed in last 9 months and holds 74.37 stake as on 31 Mar 2025
            • Other investor holding has not changed in last 9 months and holds 25.62 stake as on 31 Mar 2025
        • 4. What are the returns for Source Natural share?
          Return Performance of Source Natural Shares:
          • 1 Week: Source Natural share price moved up by 2.95%
          • 1 Month: Source Natural share price moved up by 10.23%
          • 3 Month: Source Natural share price moved up by 30.86%
          • 6 Month: Source Natural share price moved down by 19.28%
        • 5. What is the PE & PB ratio of Source Natural?
          The PE ratio of Source Natural stands at 38.77, while the PB ratio is 5.04.
        • 6. What's the market capitalization of Source Natural?
          Within the Pharmaceuticals sector, Source Natural stock has a market cap rank of 132. Source Natural has a market cap of Rs 112.74 Cr.
        • 7. Who's the chairman of Source Natural?
          Narayanan Narasimhan is the Chairman & Non-Exe.Director of Source Natural
        • 8. What is the CAGR of Source Natural?
          The CAGR of Source Natural is 20.19.
        • 9. What are the Source Natural quarterly results?
          On Standalone basis, Source Natural reported a total income and profit of Rs 16.12 Cr and Rs 0.63 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2025-03-31 was Rs 45.00 Cr and Rs 2.90 Cr.
        • 10. How can I quickly analyze Source Natural stock?
          Key Metrics for Source Natural are:
          • PE Ratio of Source Natural is 38.75
          • Price/Sales ratio of Source Natural is 2.98
          • Price to Book ratio of Source Natural is 5.79
        • 11. Who are peers to compare Source Natural share price?
          Top 10 Peers for Source Natural are Samrat Pharmachem Ltd., Welcure Drugs & Pharmaceuticals Ltd., Bharat Immunological & Biologicals Corporation Ltd., Mercury Laboratories Ltd., Makers Laboratories Ltd., Aarey Drugs & Pharmaceuticals Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Ind-Swift Ltd., Sunil Healthcare Ltd. and Auro Laboratories Ltd.

        Trending in Markets

        Top Gainers As on 03:59 PM | 13 Jun 2025

        RattanIndia Infra59.78
        12.17 (25.56%)
        Wockhardt1,776.20
        270.80 (17.99%)
        Manappuram Finance279.54
        31.98 (12.92%)
        Oil India Ltd477.75
        53.30 (12.56%)
        Capri Global171.13
        19.09 (12.56%)

        Top Losers As on 03:57 PM | 13 Jun 2025

        Netweb Technologies1,781.80
        -194.80 (-9.86%)
        Cochin Shipyard2,161.60
        -230.90 (-9.65%)
        Angel One2,924.90
        -292.10 (-9.08%)
        Brainbees Solutions378.10
        -36.80 (-8.87%)
        United Spirits1,453.10
        -140.30 (-8.81%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times